BNC2 rs10756819: Understanding Your Genetic Pigmentation Markers
The rs10756819 variant is a non-coding genetic marker located within the BNC2 gene locus. It is statistically associated with variations in human skin color saturation, freckling, and the development of facial solar lentigines.
What each genotype means
Tendency toward lighter skin saturation
You carry two copies of the A allele at rs10756819, which is in strong linkage disequilibrium with a regulatory enhancer variant controlling BNC2 expression. In genome-wide association studies, this genotype correlates with reduced BNC2 transcription in melanocytes, predisposing individuals to lighter skin color saturation, freckling, and sun-induced lentigines. Because pigmentation is a complex multigenic trait, overall coloration and UV response also depend heavily on other genes and lifetime sun exposure.
Carried by approximately 30% to 35% of individuals of European descent, but extremely rare in sub-Saharan African populations and absent in East Asian populations.
Intermediate skin saturation profile
You carry one copy of the A allele and one copy of the G allele at the BNC2-linked rs10756819 variant. Research indicates an additive regulatory effect, where heterozygous individuals exhibit intermediate levels of BNC2 enhancer activity and expression in melanocytes relative to homozygous genotypes. This results in an intermediate baseline likelihood for traits like skin color saturation and solar lentigines compared to those with AA or GG genotypes.
Found in roughly 45% to 50% of European ancestry cohorts, while remaining rare or absent across most African and East Asian groups.
Tendency toward darker skin saturation
You carry two copies of the ancestral G allele at rs10756819. Published functional studies link this genotype to higher BNC2 expression due to greater chromatin accessibility in an adjacent enhancer element, which associates statistically with deeper skin saturation and fewer light-pigmentation traits such as facial freckling. This variant represents only one modest contributor among many genetic and environmental factors that shape skin tone and photoaging.
Carried by around 15% to 20% of European populations, but represents the predominant or near-fixed genotype in African and East Asian populations.
What is rs10756819?
The variant rs10756819 is a single nucleotide polymorphism (SNP) located in the first intron of the BNC2 gene on chromosome 9. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. Because this specific variant is located in a non-coding region—meaning it does not provide instructions for making a protein directly—it is classified as a regulatory SNP. Research suggests that such variants often influence how genes are turned on or off rather than changing the structure of the protein itself. While rs10756819 is the marker often cited in association studies, scientists have identified that it exists in high linkage disequilibrium with other nearby variants, such as rs12350739, which may be the functional element influencing gene expression in melanocytes.
The Role of the BNC2 Gene
The BNC2 gene encodes the basonuclin 2 protein, which is a conserved zinc finger transcription factor. Transcription factors are proteins that bind to specific DNA sequences to regulate the transcription of genetic information from DNA to messenger RNA. BNC2 is expressed in various tissues, including the ovaries, kidneys, and skin. In the context of skin biology, BNC2 plays a significant role in melanocytes, the cells responsible for producing melanin, the pigment that determines skin, hair, and eye color. By acting as a regulator, BNC2 helps control the expression levels of genes involved in pigmentation. Research indicates that the accessibility of the chromatin surrounding the BNC2 locus can influence how much of this protein is produced, which in turn correlates with observable differences in skin pigmentation and the density of pigmented spots.
Research and Evidence Strength
The association between rs10756819 and human pigmentation is supported by genome-wide association studies (GWAS). Researchers have observed correlations between this variant and traits such as skin color saturation, freckling, and facial solar lentigines. However, the evidence strength for this specific SNP is considered limited in terms of clinical diagnostic utility. While statistical links are robust in certain cohorts, such as the Dutch population, the biological mechanism is complex. Studies have shown that the variant influences the activity of an enhancer element, which modulates BNC2 expression. When the enhancer is more active, BNC2 expression increases, which is associated with darker skin pigmentation. Conversely, lower expression is associated with lighter skin. Because these traits are polygenic—meaning they are influenced by many different genes and environmental factors—this single SNP provides only a small piece of the overall genetic puzzle regarding human appearance.
What You Can Do With This Information
Understanding your genotype for rs10756819 offers insight into the genetic factors that contribute to your natural skin pigmentation and susceptibility to freckling. It is important to recognize that this information is for educational purposes only and does not constitute a medical diagnosis or a prediction of health outcomes. Genetic variants like rs10756819 are part of the natural variation found in human populations and do not indicate a disease state. If you have concerns about skin health, such as changes in moles or the development of new pigmented spots, you should consult a dermatologist. A healthcare professional can provide personalized advice regarding skin protection and monitoring. Do not use genetic data to make decisions about medical treatments or to ignore standard clinical screenings, as your overall health is determined by a combination of genetics, lifestyle, and environmental exposures.
How common is this variant?
The minor allele frequency for rs10756819 is approximately 0.45 in European populations. Frequency varies significantly across global populations, being rare in sub-Saharan African groups and absent in many East Asian populations.
Frequently asked questions
Is rs10756819 a disease-causing mutation?
No, rs10756819 is a common genetic variant associated with normal human variation in skin pigmentation and freckling. It is not considered a disease-causing mutation.
Can I use this SNP to predict my exact skin color?
No, skin color is a complex trait influenced by many different genes and environmental factors. This single SNP only provides a small amount of information regarding pigmentation.
Does this variant affect my risk of skin cancer?
While some pigmentation genes are linked to skin cancer risk, rs10756819 is primarily studied for its role in skin color saturation and freckling. Always consult a dermatologist for skin cancer risk assessments.
Why is the evidence for this variant called 'limited'?
The term 'limited' refers to the fact that while statistical associations exist, the variant's role is part of a much larger, complex network of genes. It is not a definitive predictor of any single health outcome.
Sources & further reading
Educational information only, last refreshed 10/19/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs10756819?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in BNC2
Variant in BNC2 associated with skin pigmentation, solar lentigines, and photo-aging traits.
Regulatory variant near BNC2 strongly linked to UV-induced hyperpigmentation, age spots, and uneven skin tone in population-wide GWAS.
This SNP is associated with the onset of adolescent idiopathic scoliosis in certain populations.
This SNP in the BNC2 gene is a genetic determinant of pigmentation and is associated with the development of facial pigmented spots.
Regulatory variant in BNC2 linked to skin pigmentation variation and risk of photo-induced freckling and actinic lentigines.